Business Combination Prospectus (Form 425)

Founded in 1998, TAE's next phase focuses on deploying commercial, utility scale fusion energy. Planned power plants would provide reliable, affordable, carbon-free electricity and industrial heat without the risks of nuclear meltdown, radioactive waste, or proliferation. These advancements position TAE to offer dispatchable, affordable energy at a time of surging power demand.

In addition to its fusion business, TAE has two partially-owned subsidiaries -- TAE Power Solutions and TAE Life Sciences. The power business has developed innovative energy storage and power delivery systems to serve multiple industries, including A.I. data centers, industrial users, and electric vehicles. TAE Life Sciences has developed a biologically targeted radiotherapy to treat cancer patients.

Important Information About the Proposed Transaction and Where to Find It

In connection with the proposed transaction, TMTG intends to file with the U.S. Securities and Exchange Commission (the "SEC") a registration statement on Form S-4 to register the common stock of TMTG ("TMTG Shares") to be issued in connection with the proposed transaction. The registration statement will include a document that serves as a proxy statement and prospectus of TMTG and consent solicitation statement of TAE (the "proxy statement/prospectus and consent solicitation statement"), and TMTG will file other documents regarding the proposed transaction with the SEC. This document is not a substitute for the registration statement, the proxy statement/prospectus and consent solicitation statement, or any other document that TMTG may file with the SEC. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT, THE PROXY STATEMENT/PROSPECTUS AND CONSENT SOLICITATION STATEMENT, AND ANY OTHER RELEVANT DOCUMENTS THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT TMTG AND TAE, THE PROPOSED TRANSACTION, THE RISKS RELATED THERETO, AND RELATED MATTERS.

After the registration statement has been declared effective, a definitive proxy statement will be mailed to the shareholders of TMTG (the "TMTG Shareholders") and a prospectus and consent solicitation statement will be sent to the stockholders of TAE. Investors and security holders will be able to obtain free copies of the registration statement and the proxy statement/prospectus and consent solicitation statement, as each may be amended or supplemented from time to time, and other relevant documents filed by TMTG with the SEC (if and when they become available) through the website maintained by the SEC at www.sec.gov. Copies of documents filed with the SEC by TMTG, including the proxy statement/prospectus and consent solicitation statement (when available), will be available free of charge from TMTG's website at tmtgcorp.com under the "Investors" tab.

Participants in the Solicitation

TMTG and certain of its directors and executive officers and TAE and certain of its directors and executive officers, may be deemed to be participants in the solicitation of proxies from the TMTG Shareholders with respect to the proposed transaction under the rules of the SEC. Information regarding the names, affiliations and interests of certain of TMTG's directors and executive officers in the solicitation by reading TMTG's Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the SEC on February 14, 2025, TMTG's subsequent Quarterly Reports on Form 10-Q filed with the SEC on May 9, 2025, August 1, 2025 and November 7, 2025, respectively, TMTG's definitive proxy statement for the 2025 annual meeting of shareholders filed with the SEC on March 18, 2025 and the proxy statement/prospectus and consent solicitation statement and other relevant materials filed with the SEC in connection with the proposed transaction when they become available. Free copies of these documents may be obtained as described in the paragraphs above. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of the TMTG Shareholders in connection with the proposed transaction, including a description of their direct and indirect interests, by security holdings or otherwise, will also be set forth in the proxy statement/prospectus and consent solicitation statement and other relevant materials when filed with the SEC.

TMTG to Merge with TAE Advancing America's energy dominance and powering the A.I. revolution

Disclaimer 2 Forward-Looking Statements This presentation contains forward-looking statements. All statements, other than statements of present or historical fact included in this presentation, regarding Trump Media and Technology Group Corp.'s ("TMTG") proposed merger with TAE Technologies, Inc. ("TA E"), TMTG's ability to consummate the transaction, the benefits o f the transactio n and the combined company's future financial perfo rmance, as well as the combined company's strategy, future operations, estimated financial position, estimated revenues and losses, projected costs, prospects, plans and objectives of management are forward-looking statements. These statements are based on current expectations and assumptio ns and are subject to risks and uncertainties that co uld cause actual results to differ materially. Words such as "anticipate," "believe," "expect," "intend," "may," "plan," "pro ject," "should," "will" and similar expressio ns are intended to identify forward-looking statements, though not all forward-looking statements contain these identifying words, and the absence of these words does not mean that a statement is not forward-looking. Such forward-looking statements include, but are no t limited to, statements regarding TMTG's and TAE's expectations, hopes, beliefs, intentio ns or strategies regarding the future including, without limitation, statements regarding: the anticipated timing and terms of the proposed transaction; plans for deployment of capital and the uses thereof; governance of the combined company; development and construction timelines; cost competitiveness of fusion-generated electricity; timing of commercialization of TA E's fusion technology and the technology of its subsidiaries; expectations regarding the time period over which the combined company's capital resources will be sufficient to fund its anticipated operations; plans for research and development programs; and future demand for power (including from artificial intelligence). These forward -looking statements are based largely on TMTG's and TA E's current expectations. These forward-looking statements invo lve k nown and unk nown risks, uncertainties and o ther important factors that may cause TMTG's or TAE 's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but no t limited to, risks related to TMTG 's or TAE 's ability to demonstrate and execute on commercial viability of its technology; legal proceedings; ability to obtain financing on acceptable terms or at all; changes in digital asset valuations; disruption to TMTG's or TAE's operations; TMTG's or TAE's ability to develop and maintain k ey strategic relationships; competition in TMTG's o r TAE 's industry; ability to access required materials at acceptable costs; delays in the development and manufacturing of fusion power plants and related technology; ability to manage growth effectively; possibility of incurring losses in the future and not being able to achieve or maintain profitability; potential generation capacities of specific reactor designs; safety and cleanliness of specific reactor designs; regulatory outlook; future market conditions; success of strategic partnerships; developments in the capital and credit markets; future financial, operational and cost performance; revenue gen eration; demand for nuclear energy; economic outlook and public perception of the nuclear energy industry; changes in laws or regulations; ability to obtain required regulatory approvals on a timely basis or at all; ability to prote ct intellectual property; adverse economic or competitive conditions; and other risks and uncertainties. In addition, TMTG and TAE caution you that the forward-looking statements contained in this presentation are subject to the following factors : (i) the occurrence of any event, change or other circumstances that could delay the proposed transaction or give rise to the termination of the agreements related thereto; (ii) the outcome of any legal proceedings that may be inst ituted against TMTG or TAE following announcement of the proposed transaction; (iii) the inability to complete the proposed transaction due to the failure to obtain approval of the shareholders of TMTG or TAE, or other conditions to closing in the merger agreement; (iv) the risk that the proposed transactio n disrupts TMTG's o r TAE 's current plans and operations as a result of the announcement of the proposed transaction; (v) TMTG's and TA E's ability to realize the antic ipated benefits of the proposed transaction, which may be affected by, among other things, competition and the ability of TMTG and TAE to grow and manage growth profitably following the proposed transaction; and (vi) costs related to th e proposed transaction. The forward-looking statements in this press release are based upon information available to TMTG and TAE as of the date of this press release and, while TMTG and TAE believe such information forms a reasonable basis for such statements, these statements are inherently uncertain, and you are cautioned not to unduly rely upon these statements. Except as required by applicable law, TMTG and TAE do not plan to publicly update or revise any forward-looking statements contained in this press release, whether as a result of any new information, future events or otherwise. Additional information concerning these and other factors that may impact the operations and proj ections discussed herein can be found in TMTG 's periodic filings with the SEC, including TMTG's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, TMTG's subsequent Quarterly Repo rts on Form 10 -Q and in the Form S-4, when filed. TMTG's SEC filings are available publicly on the SEC's website at www.sec.gov. Participants in the Solicitation TMTG and certain of its directors and executive officers and TAE and certain of its directors and executive officers may be deemed to be participants in the solicitation of proxies from the TMTG Shareholders with respect to the proposed transaction under the rules o f the SEC. Info rmation regarding the names, affiliations and interests of certain of TMTG's directors and executive officers in the so licitation by reading TMTG 's Annual Report on Form 10 -K for the fiscal year ended December 31, 2024 filed with the SE C on February 14, 2025, TMTG's subsequent Quarterly Reports on Form 10 -Q filed with the SEC on May 9, 2025, August 1, 2025 and November 7, 2025, respectively, TMTG's definitive proxy statement for the 2025 annual meeting of shareholders filed with the SEC on March 18, 2025 and the proxy statement/prospectus and conse nt solicitation statement and other relevant materials filed with the SEC in connection with the proposed transaction when they become available. Free copies of these documents may be obtained as described in the paragraphs above. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of the TMTG Shareholders in connection with the proposed transaction, including a description of their direct and indirect interests, by security holdings or otherwise, will also be set forth in the proxy statement/prospectus and consent solicitation statement and other relevant materials when filed with the SEC. Important Information About the Proposed Transaction and Where to Find It In connection with the proposed transaction, TMTG intends to file with the U.S. Securities and Exchange Commissio n (the "SEC") a registration statement on Form S-4 to register the common sto ck of TMTG ("TMTG Shares") to be issued in connection with the proposed transaction. The registration statement will include a document that serves as a proxy statement and prospectus of TMTG and consent solicitation statement of TAE (the "proxy statement/prospectus and consent solicitation statement"), and TMTG will file other documents regarding the proposed transactio n with the SE C. This do cument is not a substitute for the registration statement, the proxy statement/prospectus and consent solicitation statement, or any other document that TMTG may file with the SEC. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT, THE PROXY STATEMENT/PROSPECTUS AND CONSENT SOLICITATION STATEMENT, AND ANY OTHER RELEVANT DOCUMENTS THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT TMTG AND TAE, THE PROPOSED TRANSACTION, THE RISKS RELATED THERETO, AND RELATED MATTERS. After the registration statement has been declared effective, a definitive proxy statement will be mailed to the shareholders of TMTG (the "TMTG Shareho lders") and a prospectus and consent solicitatio n statement will be sent to the stockholders of TAE. Investors and security holders will be able to obtain free copies of the registration statement and the proxy statement/prospectus and consent solicitation statement, as each may be amended or supplemented from time to time, and other relevant documents filed by TMTG with the SEC (if and when they become available) through the website maintained by the SEC at www.sec.gov. Copies of documents filed with the SEC by TMTG, including the proxy statement/pro spectus and co nsent solicitation statement (when available), will be available free of charge from TMTG's website at tmtgcorp.com under the "Investo rs" tab. No Offer or Solicitation This presentation is not intended to and does not constitute an offer to buy or sell or the solicitation of an offer to buy o r sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Transaction highlights All Stock Transaction TMTG/TAE: approximately 50% each, on a fully diluted basis Pro forma Ticker: DJT (NASDAQ & NYSE Texas) Pro forma Company capitalized to fund first utility-scale fusion plant while continuing to grow differentiated media and technology franchises TAE has demonstrated technology and team, >25-year history As part of the transaction, TMTG has agreed to provide up to $200 million of cash to TAE and an additional $100 million is available upon initial filing of the Form S-4 Pro forma board highly accomplished: nine-member board (majority independent), including Devin Nunes, Michl Binderbauer, Donald J. Trump Jr. And Michael B. Schwab (Chairman) Next Steps Expected to close in mid-26, subject to customary closing conditions and shareholder approval by both companies Mid 26 Expected transaction close 4

TMTG: Experience with large capital raises and complex regulatory processes TMTG: Publicly listed on NASDAQ and NYSE Texas TMTG: Mission of America-first investments solidified through TAE deal TAE: 27 years of fusion research, five fusion reactors TAE: 400 employees, 62 Ph.Ds, over 1,600 patents granted TAE "fits" TMTG mandate through consistent values: Promotes energy independence Strengthens national security Bolsters U.S. businesses and manufacturing Maintains American energy dominance Future upside through TAE Power Solutions, TAE Life Sciences businesses TMTG: planning to provide significant capital to advance project developments TAE: Raised $1.3B in private capital to date Pro forma Company: conglomerate to combine leading energy innovator and growing media company Pro forma Company: America-focused mission; strong capital structure Pro forma Company on mission to realize America's promise Management: Nunes and Binderbauer to serve as Co-CEOs Board: Michael Schwab to serve as Board Chair Pro forma Company to be governed by nine- member board with diverse experience, proven track record Majority of the board will be independent TMTG to advance TAE's unrivaled, proprietary technology Pro forma Company to advance American ingenuity for the benefit of all Established infrastructure to deliver electric power, secure freedom, and provide technological solutions for Americans Creates one of the world's first publicly traded fusion cos., with innovative, growing tech and media businesses Skilled, experienced management and board of directors 4

Pro forma company to deliver clean, affordable, reliable fusion energy Recognized global leader in fusion power Five reactors built to date Targeting utility-scale power generation Future plants to be scaled to 350 - 500 MWe Fusion energy to meet A.I.-driven demand TAE's proprietary technology is safe, deployable, firm, and reliable baseload power 5 TMTG to serve as Pro forma ho lding company. Cutting edge battery and power delivery systems Innovative biologically targeted radiation therapy for cancer Financial services and fintech brand incorporating America-first investments Social media platform ensuring free speech online Ultra-fast streaming of non-woke news networks and family-friendly on-demand content

New pathway to commercialization after Norm breakthrough 2025-2031 First Fusion Power Plant 1998-2005 Component R&D Era A, B, C-1 1998 - 2005 Plasma core & fuel injection established 6' 2006-2012 Concept Validation C-2 2006 - 2012 First full-scale, integrated machine 70' 100' Norman 2016-2022 "Hot Enough" milestone, plasma at >30M°C 2013-2022 Norman Era: Proof of Science C-2U 2013 - 2016 "Long Enough" milestone, "at will" sustainment 70' 2022-2028 Norm Era: Scaling to Reactor Level Norm & Norm-U 2022 - 2028 Reactor level plasma performance at 100M°C 50' Da Vinci 2025-2031 Enables sustainable, economic power plants 150+' First Power Offtake TAE's track record of innovation advantages future value creation 4 7 Nobel Prize laureates Maxwell Prize winners on staff and advisory Scientific awards received 8 by TAE Chief Science Officer Key scientific peer reviews 200+ or scientific papers published 8+ U.S. Dept. of Energy Awards Targeting fusion-generated electricity in 2031 Paves way for power plants expected to be sized 350 - 500 MWe. 10

Robust IP position and track record of success 0 250 500 750 1000 1250 1500 1750 2000 2250 2500 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TAE has had >1,600 patents granted, licensing of proprietary products for future revenue stream TAE and partially-owned subsidiary business lines: Breakthrough reactor design; targeting fusion-generated electricity in 2031 Deliver lower cost, higher performing energy storage, applicable to AI-data center expansion Patented particle accelerator technology for a breakthrough biologically-guided radiation therapy TAE CEO Dr. Michl Binderbauer holds >100 patents, and has published in the world's leading, peer-reviewed scientific journals Track record of innovation expected to advantage pro forma Company for future value creation TAE Technologies Patents Filed and Granted Since 2000 Cumulative Patents Granted Patent Applications Filed (net) 10

TAE is a clear leader to accelerate American fusion's path to power Fusion: no long-lived radioactive waste, no pollution, uses readily available, cost-effective fuels Breakthrough reactor design: smaller, less expensive, easier to build and operate Targeting delivery of fusion-generated electricity by 2031 Modular design, site-agnostic, community-friendly Critical products sourced in U.S., readily available supply chain Future commercial power plants to target 350 - 500 MWe per plant TAE has built five fusion reactors to date. Pictured is the Norman reactor. 10

TMTG's balance sheet to provide funding to build the world's first utility-scale 50 MWe power plant Post close, Company plans to site and construct its first utility-scale fusion power plant, in accordance with the following target milestones: 2026 Site location and commence construction, pending approvals 2029 First plasma expected, marking transition to pre-commercial operations 2030 Net energy capability to validate economic viability 2031 Initial facility power operations Pro forma Company to advance Da Vinci project in 2026 Success paves way for additional power plants, expected to be sized 350 - 500 MWe Da Vinci power plant - TAE's planned first utility-scale fusion power plant. 10

Derisked financing clears path to commercialization Transaction to bolster U.S.-leadership position in nuclear fusion technology and deployment $3.1 B of financial assets on balance sheet as of third quarter 2025 Capitalization will allow for initial site selection and commencement of construction in near-term, targeting fusion-generated electricity in 2031 TMTG to invest up to $200 M into TAE and an additional $100 M upon filing a Form S-4 to derisk near term milestones and accelerate fusion's path to power $1.3B Capital raised to date from notable partners Industry-leading financial positioning 10

3,500 4,000 4,500 6,500 6,000 5,500 5,000 American fusion to address A.I. industry's call for power Total U.S. Power Demand(1) 0.76% CAGR (2012 -2024) 2.14% CAGR (2025-2040) 3,000 2,500 2012 2016 2020 2024 2028 2032 2036 2040 December 15, 2025 TWh 11 Source: WoodM ackenzie as of 5/ 21/2 025 .

Company to have majority-independent nine-member board, including Schwab, Binderbauer, Nunes, and Trump, Jr.; plan to assemble advisory board comprised of specialists with diverse backgrounds and experiences Governance: Skilled, diverse Board of Directors Michael B. Schwab Board Chair Michael B. Schwab, Founder and managing director of Big Sky Partners, has spent over two decades transforming ideas into reality through visionary investments. Michl Binderbauer, PhD Co-CEO, Board Member Dr. Michl Binderbauer, co-Founder and CEO of TAE Technologies, is the architect of TAE Technologies' research and development program, and is a co-inventor of many of the company's technological advancements. Donald Trump, Jr. Board Member Donald J. Trump Jr. is an innovator and leader in today's business world, whose inherent business sense adds a level of detail and depth to the management of all current and future Trump projects. Devin Nunes Co-CEO, Board Member Devin Nunes, CEO of Trump Media and Technology Group, oversaw the expansion of TMTG into a multi-billion dollar company and the development of the proprietary technology to launch global, interoperable, apps to protect free speech online. 12

Proven, experienced leadership Michl Binderbauer, PhD Co-CEO, Board Member Devin Nunes Co-CEO, Board Member Chairman of the President's Intelligence Advisory Board and former Chairman of the House Intelligence Committee 25 years of experience in public service addressing defense, intelligence, energy, tax, trade, and healthcare policy issues Successful track record of large capital raises including a $2.4B private placement offering Experience navigating complex SEC merger processes and regulatory issues Published multiple papers in the world's leading peer-reviewed scientific journals, including Science, Physical Review Letters, Nature Communications, among others Holds >100 U.S. and international technology patents Recipient of UC Irvine's prestigious Lauds & Laurels Award Inaugural inductee into the UCI School of Physical Sciences Hall of Fame 12

TMTG to Merge with TAE Advancing America's energy dominance and powering the A.I. revolution